For a second year in a row, the General Pharmaceutical Council (GPhC) is failing to adhere to good standards of regulation in its fitness to practise.
The Professional Standards Authority’s (PSA) review of the General Pharmaceutical Council performance against set standards of good regulation concluded that the GPhC failed to meet fitness to practise standards relating to timeliness, customer service and transparency and fairness.
Read more about the PSA’s role in fitness to practise
In particular, in terms of timeliness of the GPhC’s fitness to practise process, median time frames have increased for all three of the key stages of the fitness to practise process including an increase in the number of cases open beyond a year.
However, perhaps of more concern to pharmacists is the GPhC performance in relation to transparency and fairness. Strong concerns remain about the GPhC’s triage process. Evidence showed that criteria used to make triage decisions were, in some cases, based on criteria which were not described in the GPhC’s own guidance.
Decisions made by the GPhC Investigating Committee (IC) “decisions lacked reasoning” on a number of fronts, namely the reasons for deciding:
General Pharmaceutical Council (GPhC) Barrister
I am a leading General Pharmaceutical Council (GPhC) Defence Barrister vast experience defending pharmacists and pharmacy technicians facing fitness to practise proceedings before the GPhC.
- Applications for professional registration and appeals against decisions
- Advising on investigations and, where appropriate, interviews under caution
- Representation at interim orders hearings
- Written submissions to the investigating committee
- Representation before the fitness to practise committee
- Appeals against fitness to practice committee decisions
If you have been notified by the GPhC that you’re under investigation or are facing difficulties with your registration, contact me today for an initial free and no obligation consultation on 0207 060 1983 or Stephen.McCaffrey@kingsviewchambers.com.